Les Hopitaux De Chartres — Clinical Trial Site

60 Registered trials

32 Currently recruiting

Organisation

Les Hopitaux De Chartres

Location

Le Coudray, France

Identifier

ORG-100043183

Address

4 Rue Claude Bernard, 28630, France

Departments

#3317:Cardiology
2303:Service de Cardiologie
3317, Cardiology
Accueil Urgences
Anaestesia
Anaesthesiology and Intensive Care Medicine
Anesthésie-réanimation
Anesthesiology-critical care medicine
Cardiologie
CARDIOLOGY
Cardiology-Diabetology-Nephrology
Departement de Cardiologie
Endocrinologie, Diabetologie, Nutrition
Gérontologie
Hématologie Oncologie
Hématologie Oncologie médicale
Intensive Care Unit
Médecine interne
N/A
NA
Nephrology
Neurology
Onco-hématologie
Oncologie
ONCOLOGIE HEMATOLOGIE
Oncologie Médicale
Oncology
Oncology-Hematology
Paediatric emergency department
Pneumologie
Pneumology
Réanimation
Rheumatology
Rhumatologie
Service de cardiologie
Service de cardiologie - Rez-de-chaussée
Service de Pneumologie
Service Pédiatrie - reference centres for SCD
Unité de cardiologie interventionnelle
Unité de recherche clinique cardiologie - diabétologie - néphrologie

Clinical trials at this site (60)

Search interface

Free regimen of Dexamethasone as initial therapy for advanced relapsed/refractory multiple myeloma: an open-label randomized, non-inferiorit… Recruiting

2024-510981-18-00 Multiple Myeloma Multiple myeloma (MM) is a B cell mali 5 2024-12-12
ARGO Colchicine versus Placebo in Acute Myocarditis Patients to Reduce Late Gadolinium Enhancement Mass on Cardiac Magnetic Resonance and th… Recruiting

2024-514610-13-00 patients suffering from acute myocarditis confirmed on 5 2024-10-04
PRODIGE 98- AMPIRINOX : Randomized, multicenter, Phase III trial of adjuvant chemotherapy with modified FOLFIRINOX versus capecitabine or ge… Recruiting

2024-511070-68-01 Ampullary adenocarcinoma 5 2024-09-24
Phase III study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure and impaired kidney function Recruiting

2023-508162-15-00 Chronic HF and comorbid impairment of kidney function w 5 2024-07-12
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered-Dose Inhaler on Cardiopulmonary Outcomes in C… Recruiting

2023-507407-59-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2024-07-04
Weaning protocol for high-flow nasal oxygen therapy in the ICU - Multicenter randomized controlled trial. HiFloWEAN Recruiting

2023-504366-36-00 de novo acute respiratory failure 5 2024-02-17
RIISC Recruiting

2024-513669-38-00 Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis 5 2023-05-17
Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx) Recruiting

2022-501133-23-00 MIGRAINE 4 2023-05-11
THINK - intensification of blood pressure lowering Therapeutics based on diuretics versus usual management for uncontrolled Hypertension IN … Recruiting

2022-501494-39-00 Uncontrolled Hypertension IN patients with moderate to 5 2023-03-28
ASPIC - Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care Recruiting

2024-513327-16-00 Intensive care 5 2022-09-20
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
IFM2020-05-BENEFIT-Multicenter Open label Phase 3 study of Isatuximab plus Lenalidomide and Dexamethasone with/without Bortezomib in the Tre… Recruiting

2024-517215-67-00 Newly diagnosed Non-Frail transplant Ineligible Multipl 5 2021-06-11
Short Treatment With Omalizumab for Severe Asthma (SHORTEN) Recruiting

2024-513427-17-00 Well controlled severe allergic asthma 6 2021-05-20
Randomized phase 3 trial comparing FOLFOX to gemcitabine in metastatic first-line in patients with pancreatic adenocarcinoma and non-fit for… Recruiting

2024-511904-18-00 Pancreatic adenocarcinoma (PAC) 10 2020-07-08
Management of Anticoagulant Therapy monitored by an implantable device with telecardiology in patients with Acute Coronary Syndrome associat… Ended

2024-515433-15-02 acute coronary syndrome 6 2025-01-29
A research study to investigate the effects of CagriSema compared to placebo in people with type 2 diabetes and painful diabetic peripheral … Ended

2023-509662-38-00 Type 2 diabetes and painful diabetic peripheral neuropa 4 2025-01-22
DAPAgliflozine to attenuate cardiac RemOdeling afTEr aCuTe myOcardial infarction Ended

2024-511882-13-01 Cardiac failure 5 2024-11-19
A Study of Lepodisiran (LY3819469) in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) Ended

2023-509190-23-00 Atherosclerotic Cardiovascular Disease Elevated lp(a) 5 2024-09-03
ARTEMIS - A research study to look at how ziltivekimab works compared to placebo in people who have had a heart attack Ended

2023-506876-28-00 The medical condition we are investigating is type 1 AM 5 2024-08-01
A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu… Ended

2022-502781-24-01 ASCVD - Atherosclerotic Cardiovascular Disease 5 2024-06-05
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-OUTCOMES) Ended

2023-508630-34-00 Overweight 5 2024-05-28
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended

2022-501176-26-00 Acute Ischemic Stroke and High-Risk Transient Ischemic 5 2023-08-04
REDEFINE 3: A research study to see the effects of CagriSema in people living with diseases in the heart and blood vessels Ended

2023-506924-94-00 Cardiovascular disease 5 2023-02-28
A Study of Tirzepatide (LY3298176) on the Reduction of Morbidity and Mortality in Adults With Obesity (SURMOUNT- MMO) Ended

2022-501744-15-00 Obesity, Overweight 5 2023-01-23